Dyspepsia physical examination

Jump to navigation Jump to search

Dyspepsia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Dyspepsia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Dyspepsia physical examination On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Dyspepsia physical examination

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Dyspepsia physical examination

CDC on Dyspepsia physical examination

Dyspepsia physical examination in the news

Blogs on Dyspepsia physical examination

Directions to Hospitals Treating Dyspepsia

Risk calculators and risk factors for Dyspepsia physical examination

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Fahad Hasan, M.D.[2] Ajay Gade MD[3]]

Overview

The physical examination in dyspepsia is usually normal, and no examination finding reliably distinguishes functional dyspepsia (FD) from organic causes such as peptic ulcer disease, gastroesophageal reflux disease, or upper gastrointestinal malignancy.[1][2] Mild epigastric tenderness is the most common finding but is nonspecific.[3] The examination has two main purposes: to detect findings that fall outside the FD spectrum (a palpable mass, lymphadenopathy, organomegaly, jaundice, an acute abdomen, or signs of gastrointestinal blood loss), which redirect the diagnostic pathway, and to elicit Carnett's sign, which distinguishes chronic abdominal-wall pain from visceral pain and can spare unnecessary gastrointestinal testing.[1][2]

Physical Examination

The examination follows the history and alarm-feature review. In uncomplicated FD it is expected to be unremarkable apart from possible epigastric discomfort on palpation. A palpable mass, organomegaly, or lymphadenopathy prompts further workup.[2]

General appearance and vital signs

  • Most patients with FD appear well and have normal vital signs.
  • A cachectic, chronically distressed, or acutely ill appearance is atypical for FD and should raise concern for organic disease or a complication.
  • Tachycardia, hypotension, or orthostatic change suggests hypovolemia from upper gastrointestinal bleeding. These signs indicate a complication of ulcer disease rather than a feature of functional dyspepsia and warrant urgent assessment.[4]
  • Fever is not a feature of dyspepsia; with signs of an acute abdomen it suggests ulcer perforation or another intra-abdominal process.[4]
  • Documented weight loss warrants further investigation, although it also occurs in FD itself (see limitations).[2]

Signs of anemia or gastrointestinal blood loss

  • Conjunctival or palmar pallor may indicate anemia from occult or overt upper gastrointestinal bleeding and is an alarm finding, not a feature of uncomplicated FD.
  • Observed melena or hematemesis, or a positive fecal occult blood test, points to complicated ulcer disease or malignancy and moves the patient off the FD pathway.[3]
  • A digital rectal examination and visual inspection of the perineum are part of the focused evaluation of chronic abdominal pain and support assessment for occult or overt gastrointestinal blood loss.[5]

Abdominal examination

The abdominal examination is the highest-yield component.

Abdominal examination findings in dyspepsia
Finding Clinical significance Implication
Epigastric tenderness Most frequent finding; occurs in peptic ulcer disease, reflux disease, and FD alike[3][2] Nonspecific; does not confirm any single diagnosis
Palpable epigastric or abdominal mass Suggests malignancy or another structural lesion[2] Cross-sectional imaging and upper endoscopy
Left supraclavicular (Virchow) or periumbilical (Sister Mary Joseph) lymphadenopathy Suggests gastric cancer or other intra-abdominal malignancy[2] Malignancy workup regardless of how typical the symptoms appear
Hepatomegaly, nodular liver, or palpable gallbladder Suggests hepatobiliary disease, including hepatocellular carcinoma[2] Redirect evaluation toward a hepatobiliary cause
Jaundice (skin or scleral) Suggests a biliary or pancreatic source Investigate with tests other than endoscopy, such as imaging[6]
Rigidity, guarding, or rebound tenderness Suggests perforated ulcer or peritoneal inflammation Emergency evaluation[4]
Succussion splash several hours after a meal Suggests gastric outlet obstruction or gastroparesis rather than FD Evaluate for obstruction or a gastric emptying disorder[7]

Carnett's sign

Carnett's test distinguishes chronic abdominal-wall pain, most often anterior cutaneous nerve entrapment syndrome (ACNES), from visceral pain.[1][5]

  • Technique: identify the point of maximal tenderness (typically a small area of 2 cm or less at the lateral border of the rectus abdominis), then have the patient tense the abdominal wall by raising the head and shoulders, or the straightened legs, off the table without using the arms.
  • Interpretation: tenderness that is unchanged or worse with muscle contraction is a positive test and indicates an abdominal-wall (musculoskeletal or neuropathic) origin; tenderness that decreases suggests a visceral source, because the tensed muscles shield the viscera.
  • Clinical value: anterior cutaneous nerve entrapment syndrome is a frequent and commonly missed cause of chronic abdominal pain, and routine use of Carnett's test reduces unnecessary investigation. Local anesthetic trigger-point injection producing 50% or greater relief is the confirmatory step.[8][9]
  • Limitation: the test is much less reliable in the acute abdomen and should not be used to exclude intra-abdominal pathology in that setting.[9]

Signs supporting a functional (centrally mediated) process

The following behavioral signs support a disorder of gut–brain interaction but do not by themselves establish FD:[5]

  • Absence of autonomic arousal (no tachycardia, hypertension, or diaphoresis) at the moment of reported pain
  • Closed-eyes sign: the patient closes the eyes and winces during palpation
  • Stethoscope sign: palpation with the stethoscope elicits less pain behavior than manual palpation
  • Multiple surgical scars without clear indications

Interpreting the examination

  • A normal examination is the expected finding in FD and, in the absence of alarm findings, supports rather than refutes the diagnosis.[1]
  • Epigastric tenderness should not be used to confirm peptic ulcer disease, reflux disease, or FD.[3]
  • Apply Carnett's test to any patient with focal, superficial abdominal tenderness before pursuing repeated endoscopy, imaging, or laboratory testing.[1]
  • A palpable mass, lymphadenopathy, organomegaly, jaundice, an acute abdomen, hemodynamic instability, pallor, or evidence of gastrointestinal blood loss moves the patient off the FD pathway and mandates imaging and/or endoscopy.[2][4]
  • The examination should specifically search for these alarm findings; documenting normal cardiopulmonary findings does not substitute for this.
  • Interpret examination findings alongside age: ACG/CAG recommend upper endoscopy for patients aged 60 years or older, whereas in patients younger than 60 an isolated alarm feature does not by itself mandate endoscopy.[6]

Limitations of the evidence

  • No prospective study has quantified the sensitivity or specificity of epigastric tenderness for FD versus organic disease, so its diagnostic accuracy remains undefined.
  • Reported performance of Carnett's test varies widely by setting (useful in chronic pain, unreliable in the acute abdomen), and there is no standardized method of elicitation.[9]
  • Weight loss occurs in FD itself: up to 16% of a large Belgian FD cohort reported loss of more than 10 kg. Its presence therefore does not automatically indicate malignancy, but it still warrants investigation.[2]

References

  1. ↑ 1.0 1.1 1.2 1.3 1.4 Ford et al. Lancet. 2020.
  2. ↑ 2.00 2.01 2.02 2.03 2.04 2.05 2.06 2.07 2.08 2.09 Enck et al. Nature Reviews Disease Primers. 2017.
  3. ↑ 3.0 3.1 3.2 3.3 Vakil. JAMA. 2024.
  4. ↑ 4.0 4.1 4.2 4.3 Almadi et al. Lancet. 2024.
  5. ↑ 5.0 5.1 5.2 Fukudo et al. Gastroenterology. 2026.
  6. ↑ 6.0 6.1 Moayyedi et al. American College of Gastroenterology and Canadian Association of Gastroenterology (ACG/CAG) clinical guideline on the management of dyspepsia. 2017.
  7. ↑ ASGE Standards of Practice Committee. The Role of Endoscopy in Gastroduodenal Obstruction and Gastroparesis. 2011.
  8. ↑ Shian and Larson. American Family Physician. 2018.
  9. ↑ 9.0 9.1 9.2 Sun et al. Current Pain and Headache Reports. 2024.

Template:WH Template:WS